Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
capecitabine (xeloda) (2 trials)
phy906 (3 trials)
Carcinoma (Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Colorectal Neoplasms (Phase 2)
Diarrhea (Phase 2)
Liver Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 2)
Trials (3 total)
Trial APIs (2 total)